7-116526650-C-T

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The ENST00000614113.5(CAV1):​c.334C>T​(p.Gln112*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00634 in 1,614,128 control chromosomes in the GnomAD database, including 518 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. Q112Q) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.034 ( 295 hom., cov: 32)
Exomes 𝑓: 0.0034 ( 223 hom. )

Consequence

CAV1
ENST00000614113.5 stop_gained

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 1.02

Publications

3 publications found
Variant links:
Genes affected
CAV1 (HGNC:1527): (caveolin 1) The scaffolding protein encoded by this gene is the main component of the caveolae plasma membranes found in most cell types. The protein links integrin subunits to the tyrosine kinase FYN, an initiating step in coupling integrins to the Ras-ERK pathway and promoting cell cycle progression. The gene is a tumor suppressor gene candidate and a negative regulator of the Ras-p42/44 mitogen-activated kinase cascade. Caveolin 1 and caveolin 2 are located next to each other on chromosome 7 and express colocalizing proteins that form a stable hetero-oligomeric complex. Mutations in this gene have been associated with Berardinelli-Seip congenital lipodystrophy. Alternatively spliced transcripts encode alpha and beta isoforms of caveolin 1.[provided by RefSeq, Mar 2010]
CAV1 Gene-Disease associations (from GenCC):
  • pulmonary arterial hypertension
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • congenital generalized lipodystrophy type 3
    Inheritance: AR, AD Classification: DEFINITIVE, MODERATE, LIMITED Submitted by: G2P, Ambry Genetics, ClinGen
  • partial lipodystrophy, congenital cataracts, and neurodegeneration syndrome
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • pulmonary hypertension, primary, 3
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • heritable pulmonary arterial hypertension
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Berardinelli-Seip congenital lipodystrophy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • amyotrophic lateral sclerosis
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • lipodystrophy
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 7-116526650-C-T is Benign according to our data. Variant chr7-116526650-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 128610.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.113 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000614113.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CAV1
NM_001753.5
MANE Select
c.156C>Tp.Val52Val
synonymous
Exon 2 of 3NP_001744.2
CAV1
NM_001172895.1
c.63C>Tp.Val21Val
synonymous
Exon 2 of 3NP_001166366.1Q59E85
CAV1
NM_001172896.2
c.63C>Tp.Val21Val
synonymous
Exon 1 of 2NP_001166367.1Q03135-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CAV1
ENST00000614113.5
TSL:1
c.334C>Tp.Gln112*
stop_gained
Exon 3 of 4ENSP00000479447.2A0A7P0YWJ6
CAV1
ENST00000341049.7
TSL:1 MANE Select
c.156C>Tp.Val52Val
synonymous
Exon 2 of 3ENSP00000339191.2Q03135-1
CAV1
ENST00000393467.1
TSL:1
c.63C>Tp.Val21Val
synonymous
Exon 1 of 2ENSP00000377110.1Q03135-2

Frequencies

GnomAD3 genomes
AF:
0.0341
AC:
5184
AN:
152160
Hom.:
295
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.116
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0184
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.0000943
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000367
Gnomad OTH
AF:
0.0292
GnomAD2 exomes
AF:
0.00890
AC:
2238
AN:
251354
AF XY:
0.00651
show subpopulations
Gnomad AFR exome
AF:
0.118
Gnomad AMR exome
AF:
0.00700
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000396
Gnomad OTH exome
AF:
0.00587
GnomAD4 exome
AF:
0.00345
AC:
5037
AN:
1461850
Hom.:
223
Cov.:
32
AF XY:
0.00292
AC XY:
2123
AN XY:
727220
show subpopulations
African (AFR)
AF:
0.118
AC:
3954
AN:
33480
American (AMR)
AF:
0.00751
AC:
336
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000336
AC:
29
AN:
86244
European-Finnish (FIN)
AF:
0.000131
AC:
7
AN:
53398
Middle Eastern (MID)
AF:
0.00572
AC:
33
AN:
5768
European-Non Finnish (NFE)
AF:
0.000201
AC:
224
AN:
1112004
Other (OTH)
AF:
0.00752
AC:
454
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
285
570
856
1141
1426
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
126
252
378
504
630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0341
AC:
5195
AN:
152278
Hom.:
295
Cov.:
32
AF XY:
0.0327
AC XY:
2435
AN XY:
74470
show subpopulations
African (AFR)
AF:
0.116
AC:
4825
AN:
41554
American (AMR)
AF:
0.0184
AC:
281
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5172
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4824
European-Finnish (FIN)
AF:
0.0000943
AC:
1
AN:
10610
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000368
AC:
25
AN:
68022
Other (OTH)
AF:
0.0289
AC:
61
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
230
460
690
920
1150
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
52
104
156
208
260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0150
Hom.:
99
Bravo
AF:
0.0384
Asia WGS
AF:
0.00549
AC:
20
AN:
3478
EpiCase
AF:
0.000436
EpiControl
AF:
0.000533

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
2
not specified (2)
-
-
1
Inborn genetic diseases (1)
-
-
1
Pulmonary hypertension, primary, 3 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.25
CADD
Benign
12
DANN
Benign
0.96
PhyloP100
1.0
PromoterAI
-0.090
Neutral
Mutation Taster
=18/82
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10029; hg19: chr7-116166704; API